Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy
Journal of Thoracic Oncology, 2023
A cross-cohort examination of factors impacting immunotherapy survival in non-small cell lung cancer (NSCLC)
Journal for ImmunoTherapy of Cancer, 2023
Challenges in predicting ICI response in HPV+ HNSCC: insights into the tumor microenvironment
Journal for ImmunoTherapy of Cancer, 2023
Correlating RNA-seq detection and IHC staining of potential antibody-drug conjugate (ADC) targets: HER3, HER2, TROP2, Nectin4, and aFLR
Journal for ImmunoTherapy of Cancer, 2023
Integrated immunoprofiling and RNA sequencing (RNA-seq) for anti-PD-1 response prediction in head and neck squamous cell carcinomas (HNSCC)
Journal for ImmunoTherapy of Cancer, 2023
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Nature, 2023
Comparative analysis of cfDNA liquid biopsy and tumor-based next-generation sequencing (NGS) approaches
Annals of Oncology, 2023
Comprehensive profiling of chordoma reveals tumor microenvironment subtypes and unique molecular findings
Annals of Oncology, 2023
Transcriptomic analysis and tumor microenvironment (TME) classification reveals unique immune biology in HIV patients with Kaposi sarcoma (KS)
Annals of Oncology, 2023
XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells
Cancer Research, 2023
Contact us